XOPENEX Side Effects

7024354-5 | Anaemia, Eye Operation, Intraocular Pressure Increased, Kidney Infection, Myelitis, Thrombosis, Visual Acuity Reduced, Vitamin B12 Deficiency
on Sep 15, 2010 Female patient from UNITED STATES , 59 years of age, weighting 229.9 lb, was diagnosed with asthma (What is asthma?), restrictive pulmonary disease and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, eye operation, intraocular pressure increased, kidney infection, myelitis, thrombosis, visual acuity reduced, vitamin b12 deficiency. Xopenex dosage: 1.25 Ng.3ml;prn;inhalation, 0.31 Mg/3ml;tid;inhalation. During the same period patient was treated with CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ), REQUIP (View Requip Review and Requip Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), LASIX (View Lasix Review and Lasix Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6995160-2 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Hyponatraemia, Pneumonia
Patient was taking Xopenex (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated, hyponatraemia, pneumonia (What is pneumonia?) on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with chronic obstructive pulmonary disease and. Xopenex dosage: Prn; Inhalation, Prn; Inhalation. During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), COD LIVER (View Cod Liver Review and Cod Liver Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MAXALT (View Maxalt Review and Maxalt Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6984795-9 | Aortic Aneurysm, Breast Cancer Female, Ear Infection
Adverse event was reported on Sep 02, 2010 by a Female patient taking Xopenex (View Usage) (Dosage: Prn;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 71 years of age, After Xopenex was administered, patient had the following side effects: aortic aneurysm (What is aortic aneurysm?), breast cancer female, ear infection (What is ear infection?). During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), PROVENTIL HFA / 00139501/ (View Proventil Hfa / 00139501/ Review and Proventil Hfa / 00139501/ Label ).

6979052-0 | Bronchitis, Lung Neoplasm Malignant, Oropharyngeal Pain, Product Odour Abnormal
on Aug 26, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), lung neoplasm malignant, oropharyngeal pain, product odour abnormal. Xopenex dosage: 1.25 Mg/3ml; Tid; Inhalation. During the same period patient was treated with COMBIVENT (View Combivent Review and Combivent Label ), OXYGEN (View Oxygen Review and Oxygen Label ).


6972563-3 | Balance Disorder, Chest Pain, Diastolic Dysfunction, Fall, Head Injury, Left Atrial Dilatation, Mitral Valve Incompetence, Musculoskeletal Chest Pain, Pleural Effusion
on Aug 23, 2010 Female patient from UNITED STATES , 67 years of age, weighting 149.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). Patient had the following side effects: balance disorder, chest pain (What is chest pain?), diastolic dysfunction, fall (What is fall?), head injury, left atrial dilatation, mitral valve incompetence, musculoskeletal chest pain, pleural effusion. Xopenex dosage: ; Prn; Inhalation. During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MAXALT /01406501/ (View Maxalt /01406501/ Review and Maxalt /01406501/ Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6945599-6 | Aortic Valve Incompetence, Asthma, Cardiac Failure Congestive, Urticaria, Vertigo
Patient was taking Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: aortic valve incompetence, asthma (What is asthma?), cardiac failure congestive, urticaria, vertigo on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 190.0 lb, was diagnosed with asthma (What is asthma?) and. Xopenex dosage: 1.25 Mg/3ml; Tid; Inhalation. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), SINGULAIR (View Singulair Review and Singulair Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), THYROID (View Thyroid Review and Thyroid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6931198-9 | Atelectasis, Back Pain, Bronchitis, Cardiomegaly, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Decubitus Ulcer, Dyspnoea
Adverse event was reported on Aug 02, 2010 by a Female patient taking Xopenex (View Usage) (Dosage: Prn;inhalation ; Q4h;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 67 years of age, weighting 130.7 lb, Patient experienced the following unwanted or unexpected effects: atelectasis, back pain (What is back pain?), bronchitis (What is bronchitis?), cardiomegaly, chronic obstructive pulmonary disease, condition aggravated, decubitus ulcer, dyspnoea. During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COD LIVER (View Cod Liver Review and Cod Liver Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RIZATRIPTAN BENZOATE (View Rizatriptan Benzoate Review and Rizatriptan Benzoate Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ). Patient was hospitalized.

6915512-6 | Bronchitis, Cardiomegaly, Decubitus Ulcer, Emphysema, Hypokalaemia, Hyponatraemia, Sinus Tachycardia, Spinal Cord Compression
on Jul 21, 2010 Female patient from UNITED STATES , 67 years of age, weighting 130.7 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), cardiomegaly, decubitus ulcer, emphysema, hypokalaemia, hyponatraemia, sinus tachycardia, spinal cord compression. Xopenex dosage: Q4h; Inhalation. During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RIZATRIPTAN BENZOATE (View Rizatriptan Benzoate Review and Rizatriptan Benzoate Label ), LIDODERM (View Lidoderm Review and Lidoderm Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6813249-5 | Apnoea, Bronchial Secretion Retention, Cardiac Arrest, Chest Discomfort, Eosinophilic Bronchitis, Fall, Loss Of Consciousness, Malaise, Respiratory Distress
on Jun 22, 2010 Male patient from UNITED STATES , child 7 years of age, weighting 50.04 lb, was diagnosed with asthma (What is asthma?) and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: apnoea, bronchial secretion retention, cardiac arrest (What is cardiac arrest?), chest discomfort, eosinophilic bronchitis, fall (What is fall?), loss of consciousness, malaise, respiratory distress. Xopenex dosage: 0.31 Mg/ 3ml; Prn; Inhalation, 0.63 Mg/ 3ml; Prn; Inhalation. During the same period patient was treated with DUONEB (View Duoneb Review and Duoneb Label ), SINGULAIR (View Singulair Review and Singulair Label ), PREVACID (View Prevacid Review and Prevacid Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), NASONEX (View Nasonex Review and Nasonex Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), CORTICOSTEROIDS FOR SYSTEMIC USE (View Corticosteroids For Systemic Use Review and Corticosteroids For Systemic Use Label ).

6799656-8 | Condition Aggravated, Dyspnoea, Treatment Noncompliance
Patient was taking Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, dyspnoea, treatment noncompliance on Jun 11, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with dyspnoea and. Xopenex dosage: ; Inhalation. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6798216-2 | Bronchiectasis, Candidiasis, Cystic Fibrosis Lung, Fungal Infection, Lymphadenopathy, Sputum Discoloured, Staphylococcal Infection, Stenotrophomonas Infection
Adverse event was reported on Jun 08, 2010 by a Female patient taking Xopenex (View Usage) (Dosage: Inhalation) was diagnosed with respiratory tract infection and. Location: UNITED STATES , 16 years of age, Patient had the following side effects: bronchiectasis, candidiasis, cystic fibrosis lung, fungal infection (What is fungal infection?), lymphadenopathy, sputum discoloured, staphylococcal infection (What is staphylococcal infection?), stenotrophomonas infection. During the same period patient was treated with IPRATROPIUM (View Ipratropium Review and Ipratropium Label ), BROMIDE (View Bromide Review and Bromide Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), PROPIONATE (View Propionate Review and Propionate Label ), NAFCILLIN (View Nafcillin Review and Nafcillin Label ), MINOCYCLINE (View Minocycline Review and Minocycline Label ), MICAFUNGIN (View Micafungin Review and Micafungin Label ). Patient was hospitalized.

6765191-6 | Agitation, Crying, Discomfort, Eye Irritation, Irritability, Pruritus, Rash
on Jun 10, 2010 Female patient from UNITED STATES , child 2 years of age, weighting 24.00 lb, was diagnosed with asthma (What is asthma?), condition aggravated and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: agitation, crying, discomfort, eye irritation, irritability, pruritus, rash (What is rash?). Xopenex dosage: 1 Ampule Every 4 Hours As Inhal.

6763937-4 | Heart Rate Increased, Nervousness, Oxygen Saturation Decreased
on Feb 06, 2010 Female patient from UNITED STATES , child 6 years of age, was diagnosed with respiratory distress and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, nervousness, oxygen saturation decreased. Xopenex dosage: 1.25 Mg/3ml 1x Inhalation; 1.25/3ml Inhalation; 1.25 Mg/3ml Prn Inhalation. Patient was hospitalized.

6742755-7 | Cardiac Disorder, Rash, Renal Failure Acute
Patient was taking Xopenex (View Usage). Patient had the following side effects: cardiac disorder, rash (What is rash?), renal failure acute on May 11, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 242.3 lb, was diagnosed with chronic obstructive pulmonary disease and. Xopenex dosage: Inhalation. During the same period patient was treated with XOPENEX HFA INHALATION (View Xopenex Hfa Inhalation Review and Xopenex Hfa Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), PROTONIX (View Protonix Review and Protonix Label ), PEPCID (View Pepcid Review and Pepcid Label ), PROVIGIL (View Provigil Review and Provigil Label ), ATROVENT (View Atrovent Review and Atrovent Label ). Patient was hospitalized.

6740752-9 | Blood Ph Decreased, Haematocrit Decreased, Haemoglobin Decreased, Lung Disorder, Pneumonia, Pulmonary Congestion, Purulent Discharge, Pyothorax
Adverse event was reported on May 11, 2010 by a Female patient taking Xopenex (View Usage) (Dosage: Prn; Inhalation) . Location: UNITED STATES , child 2 years of age, weighting 26.24 lb, After Xopenex was administered, patient had the following side effects: blood ph decreased, haematocrit decreased, haemoglobin decreased, lung disorder, pneumonia (What is pneumonia?), pulmonary congestion, purulent discharge, pyothorax. During the same period patient was treated with CETIRIZINE (CON.) (View Cetirizine (con.) Review and Cetirizine (con.) Label ), BUDESONIDE (CON.) (View Budesonide (con.) Review and Budesonide (con.) Label ), AZITHROMYCIN (CON.) (View Azithromycin (con.) Review and Azithromycin (con.) Label ).

6730489-4 | Aortic Surgery, Atrial Septal Defect Repair, Cardiac Operation, Coronary Artery Bypass, Mitral Valve Replacement, Postoperative Renal Failure, Rash
on Apr 30, 2010 Female patient from UNITED STATES , 69 years of age, weighting 242.3 lb, was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: aortic surgery, atrial septal defect repair, cardiac operation, coronary artery bypass (What is coronary artery bypass?), mitral valve replacement, postoperative renal failure, rash (What is rash?). Xopenex dosage: Inhalation. During the same period patient was treated with AEROSOL (View Aerosol Review and Aerosol Label ), PROTONIX /01263201/ (View Protonix /01263201/ Review and Protonix /01263201/ Label ), PEPCID (View Pepcid Review and Pepcid Label ), PROVIGIL (View Provigil Review and Provigil Label ), ATROVENT (View Atrovent Review and Atrovent Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6672781-8 | Mouth Haemorrhage, Pneumonia
on Mar 23, 2010 Female patient from UNITED STATES , 78 years of age, weighting 144.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). Patient had the following side effects: mouth haemorrhage, pneumonia (What is pneumonia?). Xopenex dosage: 0.63 Mg/ 3ml; Prn; Inhalation, 0.63 Mg/3ml; Prn; Inhalation. During the same period patient was treated with XOPENEX HFA (Inhalation) (View Xopenex Hfa Review and Xopenex Hfa Label ), CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6642363-2 | Dialysis, Lung Neoplasm Malignant, Renal Failure
Patient was taking Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: dialysis (What is dialysis?), lung neoplasm malignant, renal failure on Mar 03, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with dyspnoea and. Xopenex dosage: Prn; Inhalation. During the same period patient was treated with XOPENEX HFA (Inhalation) (View Xopenex Hfa Review and Xopenex Hfa Label ), LIPITOR (View Lipitor Review and Lipitor Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), EXELON (View Exelon Review and Exelon Label ), ZOLOFT /01011402/ (View Zoloft /01011402/ Review and Zoloft /01011402/ Label ).

6635847-4 | Asthma, Chest Pain, Glomus Tumour
Adverse event was reported on Feb 25, 2010 by a Female patient taking Xopenex (View Usage) (Dosage: ) . Location: UNITED STATES , 43 years of age, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), chest pain (What is chest pain?), glomus tumour. During the same period patient was treated with MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), FLUTICASONE PROPIONATE W/SALMETEROL (View Fluticasone Propionate W/salmeterol Review and Fluticasone Propionate W/salmeterol Label ), IPRATROPIUM (View Ipratropium Review and Ipratropium Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6553630-5 | Burning Sensation, Cystic Fibrosis, H1n1 Influenza, Haemoptysis, Lung Disorder
on Jan 08, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with dyspnoea and was treated with Xopenex (View Usage). Patient had the following side effects: burning sensation, cystic fibrosis, h1n1 influenza, haemoptysis, lung disorder. Xopenex dosage: 90 Ug; Tid; Inhalation; Inhalation; Prn; Inhalation; Qd; Inhalation. During the same period patient was treated with PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), ULTRASE /00150201/ (View Ultrase /00150201/ Review and Ultrase /00150201/ Label ), HUMALOG (View Humalog Review and Humalog Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ). Patient was hospitalized.

6551421-2 | Condition Aggravated, Dyspnoea, Hip Arthroplasty, Respiratory Tract Infection
on Jan 06, 2010 Female patient from UNITED STATES , 41 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: condition aggravated, dyspnoea, hip arthroplasty, respiratory tract infection. Xopenex dosage: 0.63 Mg/3ml;qid;inhalation; 0.63 Mg/3ml;q2h; Inhalation. During the same period patient was treated with IPRATROPIUM (Qid; Q2h) (View Ipratropium Review and Ipratropium Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), HUMULIN /00646001/ (View Humulin /00646001/ Review and Humulin /00646001/ Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6544663-3 | Swollen Tongue, Throat Irritation
Patient was taking Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: swollen tongue, throat irritation on Jan 20, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Xopenex dosage: One Nebule Three Times Daily Inhal.

6522216-0 | Altered State Of Consciousness, Arthralgia, Blood Calcium Increased, Blood Potassium Increased, Blood Pressure Increased, Cholelithiasis, Chronic Obstructive Pulmonary Disease, Decreased Activity
Adverse event was reported on Dec 09, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: See Image) was diagnosed with chronic obstructive pulmonary disease, osteoporosis (What is osteoporosis?) and. Location: UNITED STATES , weighting 159.0 lb, Patient had the following side effects: altered state of consciousness, arthralgia, blood calcium increased, blood potassium increased, blood pressure increased, cholelithiasis, chronic obstructive pulmonary disease, decreased activity. During the same period patient was treated with XOPENEX HFA (90 Ug;prn;inhalation) (View Xopenex Hfa Review and Xopenex Hfa Label ), CALCIUM (600 MG) (600 Mg; Tid) (View Calcium (600 Mg) Review and Calcium (600 Mg) Label ), IPRATROPIUM (Qid;inhalation) (View Ipratropium Review and Ipratropium Label ), COMBIVENT (View Combivent Review and Combivent Label ). Patient was hospitalized.

6521100-6 | Acute Coronary Syndrome, Arterial Stenosis, Atrial Fibrillation, Blood Glucose Increased, Cardiac Stress Test Abnormal, Carotid Artery Stenosis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Coronary Artery Occlusion
on Dec 09, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: acute coronary syndrome, arterial stenosis, atrial fibrillation (What is atrial fibrillation?), blood glucose increased, cardiac stress test abnormal, carotid artery stenosis, chronic obstructive pulmonary disease, condition aggravated, coronary artery occlusion. Xopenex dosage: 0.63 Mg/3ml;bid;inhalation, 0.63 Mg/3ml;bid;inhalation 1.25 Mg/3ml;inhalation. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), HYTRIN (View Hytrin Review and Hytrin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), XANAX (View Xanax Review and Xanax Label ), CRESTOR (View Crestor Review and Crestor Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FLOVENT (View Flovent Review and Flovent Label ). Patient was hospitalized.

6499771-2 | Chronic Obstructive Pulmonary Disease, Computerised Tomogram Thorax Abnormal, Condition Aggravated, Economic Problem, Lymphadenopathy Mediastinal, Productive Cough, Pyrexia, Rhonchi, Sputum Discoloured
on Nov 30, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, computerised tomogram thorax abnormal, condition aggravated, economic problem, lymphadenopathy mediastinal, productive cough, pyrexia, rhonchi, sputum discoloured. Xopenex dosage: ;inhalation ;inhalation ;q6h; Inhalation. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), OXYGEN (View Oxygen Review and Oxygen Label ), XANAX (View Xanax Review and Xanax Label ), PROZAC (View Prozac Review and Prozac Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6480695-1 | Atrial Flutter, Catheter Site Haemorrhage, Economic Problem
Patient was taking Xopenex (View Usage). Patient had the following side effects: atrial flutter, catheter site haemorrhage, economic problem on Oct 31, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 160.1 lb, was diagnosed with chronic obstructive pulmonary disease and. Xopenex dosage: 1.25 Mg/3ml; Qid; Inhalation; 1.25 Mg/3ml; Qd; Inhalation. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ), TRACLEER (View Tracleer Review and Tracleer Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM (View Potassium Review and Potassium Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6463139-5 | Haemoptysis, Heart Valve Incompetence, Mitral Valve Disease
Adverse event was reported on Nov 12, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: 1.25 Mmg/3ml;prn;inhalation) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 58 years of age, After Xopenex was administered, patient had the following side effects: haemoptysis, heart valve incompetence, mitral valve disease. During the same period patient was treated with XOPENEX HFA (90 Ug;qd;inhalation; 45 Ug;hs;inhalation) (View Xopenex Hfa Review and Xopenex Hfa Label ), ALVESCO INHALATION (View Alvesco Inhalation Review and Alvesco Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), NORETHINDRONE AND ETHINYL ESTRADIOL (View Norethindrone And Ethinyl Estradiol Review and Norethindrone And Ethinyl Estradiol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ).

6444350-6 | Abnormal Behaviour, Depressed Level Of Consciousness, Disorientation, Dyskinesia, Inappropriate Affect
on Nov 17, 2009 Female patient from UNITED STATES , child 9 years of age, weighting 85.40 lb, was diagnosed with asthma (What is asthma?) and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, depressed level of consciousness, disorientation, dyskinesia, inappropriate affect. Xopenex dosage: 1 Vial Every 8 Hrs +- Inhal.

6436783-9 | Febrile Convulsion, Grand Mal Convulsion
on Oct 27, 2009 Female patient from UNITED STATES , child 2 years of age, was diagnosed with bronchopulmonary dysplasia and was treated with Xopenex (View Usage). Patient had the following side effects: febrile convulsion, grand mal convulsion. Xopenex dosage: 1.25 Mg/3ml; 1x; Inhalation. During the same period patient was treated with ALBUTEROL /00139501/ (CON.) (View Albuterol /00139501/ (con.) Review and Albuterol /00139501/ (con.) Label ).

6409323-8 | Asthma
Patient was taking Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: asthma (What is asthma?) on Oct 19, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease, emphysema and. Xopenex dosage: . Patient was hospitalized.

6397914-2 | Atelectasis, Bronchitis, Chronic Obstructive Pulmonary Disease, Dizziness, Myalgia, Palpitations
Adverse event was reported on Sep 22, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: 0.63 Mg/3ml;prn;inhalation; 0.31 Mg/3ml; 1x; Inhalation; 0.63 Mg/3ml;q8h; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 78 years of age, Patient experienced the following unwanted or unexpected effects: atelectasis, bronchitis (What is bronchitis?), chronic obstructive pulmonary disease, dizziness (What is dizziness?), myalgia, palpitations. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TOFRANIL (View Tofranil Review and Tofranil Label ), VALIUM (View Valium Review and Valium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6388996-2 | Atrial Fibrillation, Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease, Depression, Diabetes Mellitus, Hypertension, Hypokalaemia, Hypotension, Oliguria
on Sep 17, 2009 Female patient from UNITED STATES , 85 years of age, was treated with Xopenex (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, chronic obstructive pulmonary disease, depression (What is depression?), diabetes mellitus, hypertension, hypokalaemia, hypotension, oliguria. Xopenex dosage: ; Q4h;. During the same period patient was treated with ALVESCO INHALATION (View Alvesco Inhalation Review and Alvesco Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), ATIVAN (View Ativan Review and Ativan Label ), BETAPACE (View Betapace Review and Betapace Label ), LASIX (View Lasix Review and Lasix Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6386890-4 | Blood Pressure Increased, Malaise, Oxygen Saturation Decreased, Respiratory Rate Increased, Tremor
on Oct 01, 2009 Male patient from UNITED STATES , 92 years of age, weighting 339.5 lb, was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: blood pressure increased, malaise, oxygen saturation decreased, respiratory rate increased, tremor. Xopenex dosage: 0.63 Mg Q4hours Prn Inh (9/8/09 2100 -} 9/8 @2300. During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), NORVASC (View Norvasc Review and Norvasc Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), VASOTEC (View Vasotec Review and Vasotec Label ), APRESOLINE (View Apresoline Review and Apresoline Label ).

6348640-7 | Product Quality Issue, Product Shape Issue, Respiratory Distress, Systemic Mycosis
Patient was taking Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue, product shape issue, respiratory distress, systemic mycosis on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , 44 years of age, was diagnosed with cerebrovascular accident, dyspnoea and. Xopenex dosage: 1.25 Mg/3ml; Q6h; Inhalation. Patient was hospitalized.

6348639-0 | Cerebrovascular Stenosis, Transient Ischaemic Attack
Adverse event was reported on Aug 24, 2009 by a Male patient taking Xopenex (View Usage) (Dosage: 1.25 Mg/3ml; Bid; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: cerebrovascular stenosis, transient ischaemic attack. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), OXYGEN (View Oxygen Review and Oxygen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6344604-8 | Adenoidal Disorder, Arrhythmia, Asthma, Chronic Tonsillitis, Cough, Cyanosis, Drooling, Electrocardiogram Abnormal, Left Ventricular Hypertrophy
on Aug 19, 2009 Male patient from UNITED STATES , child 1 years of age, weighting 25.35 lb, was diagnosed with asthma (What is asthma?) and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: adenoidal disorder, arrhythmia (What is arrhythmia?), asthma (What is asthma?), chronic tonsillitis, cough, cyanosis, drooling, electrocardiogram abnormal, left ventricular hypertrophy. Xopenex dosage: 0.31 Mg/3ml; Inhalation; 0.63 Mg/3ml; Inhalation; 0.63 Mg/3ml; Inhalation. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), VANTIN /01043502/ (View Vantin /01043502/ Review and Vantin /01043502/ Label ). Patient was hospitalized.

6335773-4 | Asthma, Atelectasis, Bronchospasm, Fluid Overload, Respiratory Distress
on Aug 14, 2009 Female patient from UNITED STATES , 58 years of age, weighting 150.1 lb, was diagnosed with asthma (What is asthma?), dyspnoea and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), atelectasis, bronchospasm, fluid overload, respiratory distress. Xopenex dosage: 0.63 Mg/3ml; Prn; Inhalation. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MOTRIN (View Motrin Review and Motrin Label ), INDOCIN (View Indocin Review and Indocin Label ). Patient was hospitalized.

6335137-3 | Dysphonia, Gastrooesophageal Reflux Disease, Irritable Bowel Syndrome, Product Packaging Quantity Issue, Product Substitution Issue
Patient was taking Xopenex (View Usage). Patient had the following side effects: dysphonia, gastrooesophageal reflux disease, irritable bowel syndrome (What is irritable bowel syndrome?), product packaging quantity issue, product substitution issue on Aug 28, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 210.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Xopenex dosage: 1 Every 4 Hrs As Needed About 7 Years.

6312638-5 | Confusional State, Dyspnoea, Feeling Abnormal, Hallucination
Adverse event was reported on Aug 03, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: 0.63 Mg/3ml;bid;inhalation, 0.63 Mg/3ml;tid;inhalation) was diagnosed with bronchitis (What is bronchitis?) and. Location: UNITED STATES , 95 years of age, After Xopenex was administered, patient had the following side effects: confusional state, dyspnoea, feeling abnormal, hallucination. During the same period patient was treated with Z PAK (View Z-pak Review and Z-pak Label ), ZOCOR (View Zocor Review and Zocor Label ), PAXIL (View Paxil Review and Paxil Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6299131-3 | Abdominal Discomfort, Asthenia, Feeling Abnormal, Gastrointestinal Fungal Infection, Nervousness
on Jul 21, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with asthma (What is asthma?) and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, asthenia, feeling abnormal, gastrointestinal fungal infection, nervousness. Xopenex dosage: Inhalation. During the same period patient was treated with COMBIVENT (Prn; Inhalation) (View Combivent Review and Combivent Label ), MINERAL OIL EMULSION (View Mineral Oil Emulsion Review and Mineral Oil Emulsion Label ), METAMUCIL (View Metamucil Review and Metamucil Label ), ZANTAC (View Zantac Review and Zantac Label ), HYOSCYAMINE (View Hyoscyamine Review and Hyoscyamine Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), CALCIUM W/VITAMIN D (View Calcium W/vitamin D Review and Calcium W/vitamin D Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6295544-4 | Confusional State, Feeling Abnormal, Hallucination, Hypersensitivity
on Jul 17, 2009 Female patient from UNITED STATES , 95 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Xopenex (View Usage). Patient had the following side effects: confusional state, feeling abnormal, hallucination, hypersensitivity. Xopenex dosage: 0.63 Mg/3ml; Bid; Inhalation. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), PAXIL (View Paxil Review and Paxil Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6278754-1 | Cerebrovascular Accident, Pulmonary Function Test Decreased
Patient was taking Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: cerebrovascular accident, pulmonary function test decreased on Jul 09, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with bronchiectasis, contraception and. Xopenex dosage: 1.25 Mg/3ml; Qid; Inhalation. During the same period patient was treated with ORAL CONTRACEPTIVE NOS (Oral) (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ). Patient was hospitalized.

6278753-X | Gastric Haemorrhage
Adverse event was reported on Jul 14, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: 90 Ug;tid;inhalation, Qid, Inhalation) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 69 years of age, weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: gastric haemorrhage. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), CLARITIN (View Claritin Review and Claritin Label ), FLOVENT (View Flovent Review and Flovent Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), CARTIA XT (View Cartia Xt Review and Cartia Xt Label ). Patient was hospitalized.

6267996-7 | Cellulitis, Condition Aggravated, Confusional State, Fatigue, Lethargy
on Jun 29, 2009 Male patient from UNITED STATES , 85 years of age, was diagnosed with cardiac failure congestive and was treated with Xopenex (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), condition aggravated, confusional state, fatigue, lethargy. Xopenex dosage: 1.25 Mg/3ml;prn;inhalation, 1.25 Mg/3ml;qid;inhalation. During the same period patient was treated with DUONEB (View Duoneb Review and Duoneb Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FLOMAX (View Flomax Review and Flomax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6249963-2 | Abasia, Asthenia, Blood Disorder, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Dysphonia, Feeling Abnormal, Pneumonia, Streptococcal Infection
on Jun 11, 2009 Female patient from UNITED STATES , weighting 84.22 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: abasia, asthenia, blood disorder, chronic obstructive pulmonary disease, condition aggravated, dysphonia, feeling abnormal, pneumonia (What is pneumonia?), streptococcal infection (What is streptococcal infection?). Xopenex dosage: 1.25 Mg/3ml;qid;inhalation, 0.63 Mg/3ml, Qid. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), MUCINEX (View Mucinex Review and Mucinex Label ), XANAX (View Xanax Review and Xanax Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6237738-X | Cerebrovascular Accident, Pulmonary Function Test Decreased
Patient was taking Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, pulmonary function test decreased on Jun 05, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with bronchiectasis and. Xopenex dosage: 1.25 Mg/3ml; Qid; Inhalation. During the same period patient was treated with ORAL CONTRECPTIVE NOS (Oral) (View Oral Contrecptive Nos Review and Oral Contrecptive Nos Label ). Patient was hospitalized.

6236375-0 | Aortic Valve Stenosis, Gastrointestinal Haemorrhage, Gastrointestinal Obstruction
Adverse event was reported on Jun 03, 2009 by a Female patient taking Xopenex (View Usage) (Dosage: 1.25 Mg/3ml;qid;inhalation) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , 78 years of age, weighting 130.1 lb, Patient had the following side effects: aortic valve stenosis, gastrointestinal haemorrhage, gastrointestinal obstruction. During the same period patient was treated with IPRATROPIUM BROMIDE (Qid, Inhalation) (View Ipratropium Bromide Review and Ipratropium Bromide Label ), REQUIP (View Requip Review and Requip Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6219557-3 | Blood Pressure Increased, Cheilitis, Dizziness, Dry Mouth, Gastrointestinal Disorder, Lip Dry, Mouth Injury, Oropharyngeal Swelling
on May 26, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with pulmonary congestion, sinus congestion and was treated with Xopenex (View Usage). After Xopenex was administered, patient had the following side effects: blood pressure increased, cheilitis, dizziness (What is dizziness?), dry mouth, gastrointestinal disorder, lip dry, mouth injury, oropharyngeal swelling. Xopenex dosage: 0.63 Mg/3ml; Qd; Inhalation. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), KEPPRA (View Keppra Review and Keppra Label ), ATIVAN (View Ativan Review and Ativan Label ), VALTREX (View Valtrex Review and Valtrex Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

6215414-7 | Asthma, Bradyarrhythmia, Condition Aggravated, Coronary Artery Disease, Sputum Abnormal, Syncope, Tremor
on May 20, 2009 Female patient from UNITED STATES , 83 years of age, was diagnosed with asthma (What is asthma?) and was treated with Xopenex (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bradyarrhythmia, condition aggravated, coronary artery disease (What is coronary artery disease?), sputum abnormal, syncope, tremor. Xopenex dosage: 1.25 Mg/3ml; Prn; Inhalation, 1.25 Mg/3ml;qid; Inhalation. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), DIOVAN (View Diovan Review and Diovan Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), DAILY VITAMINS (View Daily Vitamins Review and Daily Vitamins Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6177109-8 | Condition Aggravated, Irritable Bowel Syndrome, Nausea, Rash Pruritic, Urticaria
Patient was taking Xopenex (View Usage). Patient had the following side effects: condition aggravated, irritable bowel syndrome (What is irritable bowel syndrome?), nausea (What is nausea?), rash pruritic, urticaria on Apr 30, 2009 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 170.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Xopenex dosage: 1 - 2 Puffs 3x/day And Prn Inhal. During the same period patient was treated with PROAIR HFA (1-2 Puffs 3x/day And Prn Inhal) (View Proair Hfa Review and Proair Hfa Label ).